Tetanus

Rite Aid and Bartell Drugs Host Monthly Immunization Days This Summer

Retrieved on: 
Wednesday, May 1, 2024
General Health, Pharmaceutical, Health, Cold medicine, Aid, OTC, Shingles, Rite Aid, Immunization, COVID-19, Tetanus, Vaccine, RSV, Travel, HPV

Rite Aid (OTC: RADCQ) and Bartell Drugs will offer a monthly Family Immunization Day event from 10 a.m. to 6 p.m. the first Wednesday of each month, beginning May 1 through August 7 at select locations.

Key Points: 
  • Rite Aid (OTC: RADCQ) and Bartell Drugs will offer a monthly Family Immunization Day event from 10 a.m. to 6 p.m. the first Wednesday of each month, beginning May 1 through August 7 at select locations.
  • Customers who are unable to attend an Immunization Day at a participating Immunization Day location can schedule an appointment for necessary vaccinations at their local Rite Aid through the online scheduling tool .
  • Bartell Drugs customers may use their online scheduler as well.
  • To help customers determine which routine immunizations are right for them, Rite Aid offers an Immunization Evaluation Questionnaire on its website.

World Market for Vaccines 2024: From Smallpox to Polio - The Impact on Global Health - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024
Managed Care, General Health, Pharmaceutical, Medical Devices, Infectious Diseases, Hospitals, Clinical Trials, COVID-19, Biotechnology, Medical Supplies, FDA, Health, Tetanus, Molina Healthcare, Public, Vaccine, Rubella, Death, Diphtheria, Quality of life, Vaccine-preventable diseases, Disease, Smallpox, Vaccination, Measles

The World Market for Vaccines, 2024 offers the most up-to-date and comprehensive analysis of adult and pediatric preventative vaccines.

Key Points: 
  • The World Market for Vaccines, 2024 offers the most up-to-date and comprehensive analysis of adult and pediatric preventative vaccines.
  • Since the early 2000s, the publisher has consistently published new editions of The World Market for Vaccines every two years.
  • The report includes market forecasts, company market share data, and expert market estimates for different vaccine categories.
  • The World Market for Vaccines, 2024 also examines market trends for human vaccines used to prevent various diseases.

Viral Sensitizers Market Research Report 2023: Viral Vaccines, Oncolytic Viral Therapies and Viral Vectors - Global Industry Trends and Forecasts, 2020-2022 and 2023-2035 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 6, 2024
Health, Oncology, Other Health, Science Advisory Board, COVID-19, Genetic engineering, Workflow, Cell, Vector (mathematics and physics), Government, MLD, Cold medicine, Tetanus, Patient, DTP, Virus, COVID-19 vaccine, FDA, World Health Organization, AAV, Cell death, Vaccine, Infection, Measles, Gene, Viral, GMP, Immunization, WHO

The "Viral Sensitizers Market: Distribution by Application Area (Viral Vaccines, Oncolytic Viral Therapies and Viral Vectors) and Key Geographical Regions (North America, Europe and Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Viral Sensitizers Market: Distribution by Application Area (Viral Vaccines, Oncolytic Viral Therapies and Viral Vectors) and Key Geographical Regions (North America, Europe and Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035" report has been added to ResearchAndMarkets.com's offering.
  • The market research report highlights the efforts of several stakeholders engaged in this rapidly evolving segment of the viral manufacturing industry.
  • Key takeaways of the viral sensitizers market report are briefly discussed below.
  • We have extensively studied the historical market data within this industry, in order to develop a deeper understanding of the evolutionary market trends.

Phreesia Joins Call to Action to Improve Adult Vaccination Rates

Retrieved on: 
Tuesday, January 23, 2024
COVID-19, Technology, Human Resources, Public Relations, Investor Relations, Communications, Professional Services, Software, General Health, Pharmaceutical, Health, Death, Patient, Heart, MD, NFID, Diphtheria, American Pharmacists Association, Tetanus, American Medical Association, Vaccination, Disability, Infection, DPT vaccine, Cardiovascular disease, Immunization, Organization, HPV, National Forum, Vaccine, RSV

Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that it has joined the National Adult and Influenza Immunization Summit’s Call to Action for Adult Immunizations campaign to improve adult vaccination rates.

Key Points: 
  • Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that it has joined the National Adult and Influenza Immunization Summit’s Call to Action for Adult Immunizations campaign to improve adult vaccination rates.
  • More than three in four adults are missing routinely recommended vaccines and, due to preventive care put on hold during the COVID-19 pandemic, low vaccination rates have worsened.
  • The mission of the campaign is to encourage healthcare providers to take action to improve the implementation of adult vaccination recommendations to protect adults from preventable illness, disability and death.
  • Within the last few years, Phreesia has delivered over 20.7 million messages to adults to encourage conversations with care teams about recommended vaccines.

DocGo Expands Mobile Health Services with Santa Cruz County, Arizona Department of Health

Retrieved on: 
Tuesday, December 19, 2023
Health Technology, Health Insurance, Telemedicine, Virtual Medicine, Technology, Managed Care, General Health, Medical Devices, Artificial Intelligence, Biotechnology, Science, Software, Networks, Other Science, Research, Health, Mobile, Wireless, Partnership, Physician, MMR, Rural health, Tetanus, Vaccine, Diphtheria, HPV, IPV, Cold medicine, Arizona Department, Vaccination, DPT vaccine, Measles, Health care, University, DTAP, COVID, Mumps, Arizona Center, Pharmaceutical industry

(Nasdaq:DCGO), a leading provider of technology-enabled mobile health services, today announced the expansion of its vaccination and public health initiatives in Arizona through a new contract with the Department of Health in Santa Cruz County, Arizona.

Key Points: 
  • (Nasdaq:DCGO), a leading provider of technology-enabled mobile health services, today announced the expansion of its vaccination and public health initiatives in Arizona through a new contract with the Department of Health in Santa Cruz County, Arizona.
  • Beginning in late November, DocGo now operates a mobile clinic to enhance vaccine accessibility in a rural area with limited access to medical resources.
  • Santa Cruz County is designated as a medically underserved area by the Arizona Department of Health Services.
  • DocGo previously offered flu and COVID vaccines in mobile clinics with Santa Cruz County Health Department, as well as with the Maricopa County Health Department and the state of Arizona Department of Health.

Rite Aid Helps Customers Prioritize Immunity During Busy Holiday Season with Flu Shot Fridays

Retrieved on: 
Wednesday, November 29, 2023
Retail, Health, Convenience Store, Specialty, General Health, Pharmaceutical, Holiday, Cough, Shingles, Tetanus, RSV, Pharmacist, Rite Aid, Influenza vaccine, Tobacco, Weather, Vaccine, Prescription, COVID-19, QR, Rite, Virus, HPV, OTC, Travel, Online shopping

Rite Aid’s upcoming Flu Shot Fridays allows families to conveniently receive routine vaccinations ahead of the holiday season.

Key Points: 
  • Rite Aid’s upcoming Flu Shot Fridays allows families to conveniently receive routine vaccinations ahead of the holiday season.
  • Customers receiving their flu shot will also receive coupons for $5 off a $25 in-store purchase* and a free cold drink.
  • ** Flu Shot Fridays will be held every Friday from Dec. 1-29, at select locations.
  • Customers are encouraged to schedule an appointment for necessary vaccinations at their local Rite Aid through the online scheduling tool , or walk-in during regular store hours on Flu Shot Fridays.

Vera Therapeutics Presents Positive Data from Phase 2b ORIGIN Study Showing Resolution of Hematuria in Majority of Patients at the American Society of Nephrology Kidney Week 2023

Retrieved on: 
Saturday, November 4, 2023
Patient, APRIL, Hematuria, EGFR, Tetanus, Diphtheria, Immunoglobulin A, Poster, Society, American Society of Nephrology, BAFF, Disease, COVID-19, Risk, Immunity, ASN, Kidney disease, Safety, Overalls, UPCR, Therapy, Kidney, Death, Infection, Proteinuria, Mineral wool, Pharmaceutical industry, Vaccine, IgA nephropathy

BRISBANE, Calif., Nov. 04, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the presentation of three posters – including an additional analysis of week 36 data from the Phase 2b ORIGIN study demonstrating resolution of hematuria in the majority of patients – on the Company’s product candidate atacicept in patients with immunoglobulin A nephropathy (IgAN) at the American Society of Nephrology (ASN) Kidney Week 2023, in Philadelphia, PA.

Key Points: 
  • Analysis of week 36 data from Phase 2b ORIGIN study shows atacicept 150 mg substantially reduces serum Gd-IgA1 and resolves hematuria in the majority of patients.
  • Additional poster presentations provide further safety analysis of Phase 2b and details of pivotal Phase 3 clinical trial design, which is currently enrolling.
  • At week 36 of the ORIGIN Phase 2b study of atacicept in patients with IgAN, hematuria resolved in 80% of patients (n=12/15) receiving atacicept 150 mg compared to 5% (n=1/19) in the placebo group.
  • Through the randomized, placebo-controlled period, infections were balanced between atacicept and placebo in both the Phase 2a JANUS and Phase 2b ORIGIN studies.

Rite Aid to Offer After Work Wednesday Walk-In Clinic

Retrieved on: 
Monday, October 30, 2023
General Health, Pharmaceutical, Health, RSV, OTC, Shingles, Cold medicine, Pharmacist, COVID-19, Rite Aid, Virus, Tetanus, Respiratory syncytial virus, Vaccine, Travel

Rite Aid (OTC: RADCQ) makes it easy to keep your health a priority by offering an After Work Wednesday clinic at select stores, providing families a convenient opportunity to walk in and get the immunizations they need to protect themselves against the flu, COVID-19, RSV, and other viruses.

Key Points: 
  • Rite Aid (OTC: RADCQ) makes it easy to keep your health a priority by offering an After Work Wednesday clinic at select stores, providing families a convenient opportunity to walk in and get the immunizations they need to protect themselves against the flu, COVID-19, RSV, and other viruses.
  • Rite Aid’s upcoming After Work Wednesday event offers families the flexibility of a walk-in clinic, allowing them to conveniently receive routine immunizations.
  • “The health of our communities is always top of mind for Rite Aid, especially as we approach the holiday season,” said Karen Staniforth, Chief Pharmacy Officer at Rite Aid.
  • To help customers determine which routine immunizations are right for them, Rite Aid offers an Immunization Evaluation Questionnaire on its website.

Vera Therapeutics to Present Three Posters at the American Society of Nephrology Kidney Week 2023 Annual Meeting

Retrieved on: 
Friday, October 13, 2023
FRCP, Barratt, Abstract, COVID, Nephrology, Society, University, Therapy, ASN, Tetanus, University of Leicester, Diphtheria, American Society of Nephrology, Serum, Patient, Infection, Pharmaceutical industry, IgA nephropathy

BRISBANE, Calif., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that three abstracts on the Company’s product candidate atacicept in immunoglobulin A nephropathy (IgAN) have been selected for poster presentations at the American Society of Nephrology (ASN) Kidney Week 2023, which is taking place November 2–5, 2023, in Philadelphia, PA.

Key Points: 
  • Additional analysis of week 36 data from Phase 2b ORIGIN study show atacicept 150mg reduces serum Gd-IgA1, supporting atacicept’s potential as long-term disease-modifying IgAN therapy
    Atacicept showed continued protective titers to diphtheria and tetanus and balanced COVID infections vs. placebo in IgAN
    BRISBANE, Calif., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that three abstracts on the Company’s product candidate atacicept in immunoglobulin A nephropathy (IgAN) have been selected for poster presentations at the American Society of Nephrology (ASN) Kidney Week 2023, which is taking place November 2–5, 2023, in Philadelphia, PA.
    Kidney Week Poster Presentation Details:
    Jonathan Barratt, Ph.D., FRCP, The Mayer Professor of Renal Medicine, University of Leicester, UK

Global Adult Vaccines Market Research Report 2023: Market to Surpass $25 Billion by 2027 - Long-term Forecasts to 2032 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 11, 2023
Health, Pharmaceutical, Measles, DPT, Research report, Hepatitis, COVID-19, Hospital, Acquisition, Food, Vaccine, Tuberculosis, Traction, Prevalence, Meningococcal vaccine, GSK plc, SARS, Infection, World Health Organization's response to the COVID-19 pandemic, Simplex, World Health Organization, Shingles, Merck, Growth, Statistics, Lonrho, Merck & Co., Tetanus, Regulation of tobacco by the U.S. Food and Drug Administration, Sanofi, Messenger, Streptococcus, Research, Themis

Various technologies are harnessed to develop these vaccines, encompassing live attenuated vaccines, inactivated viral or bacterial vaccines, toxoid vaccines, recombinant vaccines, and conjugate vaccines.

Key Points: 
  • Various technologies are harnessed to develop these vaccines, encompassing live attenuated vaccines, inactivated viral or bacterial vaccines, toxoid vaccines, recombinant vaccines, and conjugate vaccines.
  • The adult vaccines market research report is an invaluable resource, offering a wealth of statistics on the adult vaccines market, including global market size, regional distributions, insights into market competitors with their respective market shares, comprehensive segmentation of the adult vaccines market, prevailing market trends, and promising opportunities.
  • These alarming statistics underscore the pivotal role of adult vaccines in curbing the spread of contagious diseases and substantiate the burgeoning growth of the adult vaccines market.
  • The adult vaccines market encompasses the sales of mRNA vaccines and viral vector vaccines.